Updated:
Virpax Pharmaceuticals, Inc.
Virpax Pharmaceuticals, Inc. is identified in the retained SEC EDGAR snapshot dated 2026-10-14. Its SEC Central Index Key is 0001708331, and its reported...
Overview
Virpax Pharmaceuticals, Inc. is identified in the retained SEC EDGAR snapshot dated 2026-10-14. Its SEC Central Index Key is 0001708331, and its reported industry is Pharmaceutical Preparations. In 10-K filed on 2025-03-03, it reported net income of USD -12,067,225; total assets of USD 1,555,614 for the fiscal period ended 2024-12-31. The financial history preserves reporting periods, currencies, filing accessions and source provenance. Figures are reported filing data, rather than real-time estimates.
Company overview
- Legal name
- Virpax Pharmaceuticals, Inc.
- Classification
- Company
- Industry (SIC)
- 2834 — Pharmaceutical Preparations
- Headquarters
- Berwyn, PA, United States
- Incorporated in
- DE
- Fiscal year end
- December 31
- SEC CIK
- 0001708331
Financials
Annual figures as originally reported. Currency is shown for each fiscal year; B means billion and M means million.
| Fiscal year | Period end | Net income | Total assets | Operating cash flow |
|---|---|---|---|---|
| FY2024USD | -$12.1M | $1.6M | -$16.7M | |
| FY2023USD | -$15.2M | $9.6M | -$9.9M | |
| FY2022USD | -$21.7M | $19.7M | -$17.8M | |
| FY2021USD | -$12.1M | $39.6M | -$14.5M |
Recent SEC filings
| Form | Filed | Period | Filing |
|---|---|---|---|
| 8-K | FORM 8-K | ||
| 8-K | FORM 8-K | ||
| S-1 | — | FORM S-1 | |
| 10-K | FORM 10-K | ||
| 8-K | FORM 8-K | ||
| 8-K | FORM 8-K | ||
| 8-K | FORM 8-K | ||
| 424B4 | — | FORM 424B4 | |
| 8-K | FORM 8-K | ||
| 8-K | FORM 8-K | ||
| S-1 | — | FORM S-1 | |
| 8-K | FORM 8-K |
Profile maintained by Altss. Updated: . To correct this record or make a privacy request, send the page URL and your evidence to privacy@altss.com; corrections are free.
Research Virpax Pharmaceuticals, Inc. in Altss
Track this company’s investors, transactions and relationships in Altss.